Form 4: Eli Lilly Executive Patrik Jonsson Reports Stock Transactions
SEC Form 4 Filing
Executive Vice President of Eli Lilly, Patrik Jonsson, reports the acquisition and disposal of company stock and restricted stock units.
Summary
- Patrik Jonsson, an Executive Vice President at Eli Lilly, reported transactions involving the company's stock.
- On February 12, 2024, Jonsson acquired 5,362 shares of common stock at a price of $737.26 per share.
- He also disposed of 537 shares of common stock held indirectly through a 401(k).
- Additionally, Jonsson acquired 3,433 restricted stock units, each representing a contingent right to receive one share of Eli Lilly common stock, which vest on February 1, 2025.
Sentiment
Score: 5
Explanation: The document reflects standard executive stock transactions, with no clear positive or negative implications for the company's overall outlook.
Positives
- The acquisition of 5,362 shares by an executive could be seen as a positive sign of confidence in the company's future.
Negatives
- The disposal of 537 shares, while a small amount, could be interpreted as a slight negative signal.
Risks
- Executive stock transactions can sometimes be influenced by personal financial needs rather than company performance, so it's important to consider the context.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's view of the company's prospects.
Comparison to Industry Standards
- Executive stock transactions are a standard practice across publicly listed companies, with reporting requirements mandated by the SEC.
- The volume of shares transacted by Patrik Jonsson is not unusual for an executive at his level.
- The use of restricted stock units is a common form of executive compensation, aligning management's interests with those of shareholders.
Stakeholder Impact
- The stock transactions may have a minor impact on shareholder sentiment, but are unlikely to significantly affect the company's operations or financial performance.
Key Dates
| Date | Description |
|---|---|
| 02/12/2024 | Date of the stock and restricted stock unit transactions. |
| 02/01/2025 | Vesting date for the restricted stock units. |
| 02/14/2024 | Date the form was signed. |
Keywords
Eli Lilly, LLY, stock transaction, insider trading, restricted stock units, executive compensation, Form 4, Patrik Jonsson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.